1. Полякова А. А., Давыдова В. Г, Стрельцова А. А., Крутиков А. Н., Пыко С. А., Кленина И. С. и др. Ассоциация полиморфных вариантов генов MADD и MYH7 и гипертрофической кардиомиопатии у пациентов старше 45 лет. Кремлевская медицина. Клинический вестник. 2017;(1):47-54.
2. Лясникова Е. А., Улитин А. М., Тишкова В. М., Куу-лар А. А., Муравьев А. С., Козырева А. А. и др. Генетические детерминанты, ассоциированные с развитием и прогнозом постинфарктного ремоделирования и хронической сердечной недостаточности. Трансляционная медицина. 2018;5(1):15— 24. doi: 10.18705/2311-4495-2018-5-1-15-24
3. Defer N, Azroyan A, Pecker F, Pavoine C. TNFR1 and TNFR2 signaling interplay in cardiac myocytes. J Biol Chem. 2007;282(49):35564-35573. PubMed PMID:17913704; doi:10.1074/jbc.M704003200
4. Spinale FG, Coker ML, Heung LJ, Bond BR, Gunasin-ghe HR, Etoh T et al. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation. 2000;102(16):1944-1949. doi:10.1161/01.cir.102.16.1944
5. Kurada BR, Li LC, Mulherkar N, Subramanian M, Prasad KV, Prabhakar BS. MADD, a splice variant of IG20, is indispensable for MAPK activation and protection against apoptosis upon tumor necrosis factor-alpha treatment. J Biol Chem. 2009;284(20):13533-13541. doi:10.1074/jbc.M808554200
6. Saini S, Sripada L, Tulla K, Kumar P, Yue F, Kunda N et al. Loss of MADD expression inhibits cellular growth and metastasis in anaplastic thyroid cancer. Cell Death Dis. 2019;10(2):145. doi:10.1038/s41419-019-1351-5
7. Zhang T, Hu Y, Ju J, Hou L, Li Z, Xiao D et al. Downregulation of miR-522 suppresses proliferation and metastasis of non-small cell lung cancer cells by directly targeting DENN/MADD domain containing 2D. Sci Rep. 2016;6:19346. PMID: 26783084; PMCID: PMC4726064; doi:10.1038/srep19346
8. Del Villar K, Miller CA. Down-regulation ofDENN/MADD, a TNF receptor binding protein, correlates with neuronal cell death in Alzheimer's disease brain and hippocampal neurons. Proc Natl Acad Sci USA. 2004;101(12):4210-4215. doi:10.1073/pnas.0307349101
9. Wu CK, Huang YT, Lee JK, Chiang LT, Chiang FT, Huang SW et al. Cardiac myosin binding protein C and MAP-kinase activating death domain-containing gene polymorphisms and diastolic heart failure. PLoS One. 2012;7(4):e35242. doi:10.1371/journal.pone.0035242
10. Sadayappan S, Gulick J, Osinska H, Martin LA, Hahn HS, Dorn GW et al. Cardiac myosin-binding protein-C phosphorylation and cardiac function. Circ Res. 2005;97(11): 1156-1163. doi:10.1161/01.RES.0000190605.79013.4d
11. Tong CW, Nair NA, Doersch KM, Liu Y, Rosas PC. Cardiac myosin-binding protein-C is a critical mediator of diastolic function. Pflugers Arch Eur J Physiol. 2014;466(3):451-457. doi:10.1007/s00424-014-1442-1
12. Sadayappan S, Osinska H, Klevitsky R, Lorenz JN, Sargent M, Molkentin JD et al. Cardiac myosin binding protein C phosphorylation is cardioprotective. Proc Natl Acad Sci USA. 2006;103(45):16918-16923. doi:10.1073/pnas.0607069103
13. Cho JS, Cho EJ, Lee J, Choi HD, Park KC, Lee KH et al. Myocardial mechanics in a rat model with banding and debanding of the ascending aorta. J Cardiovasc Ultrasound. 2014;22(4): 189-195. doi:10.4250/jcu.2014.22.4.189
14. Friehs I, Cowan DB, Choi YH, Black KM, Barnett R, Bhasin MK et al. Pressure-overload hypertrophy of the developing heart reveals activation of divergent gene and protein pathways in the left and right ventricular myocardium. Am J Physiol Heart Circ Physiol. 2013;304(5): H697-H708. doi:10.1152/ajpheart.00802.2012
15. van den Bosch BJ, Lindsey PJ, van den Burg CM, van der Vlies SA, Lips DJ, van der Vusse GJ et al. Early and transient gene expression changes in pressure overload-induced cardiac hypertrophy in mice. Genomics. 2006;88(4):480-488. doi:10.1016/j.ygeno.2006.04.012
16. Кузьменко Н. В., Князева А. А., Головкин А. С., Крутиков А. Н., Мишанин А. И., Павлов Г. С. и др. К анализу возможных механизмов развития унилатеральной вазоренальной гипертензии. Российский физиологический журнал им. И. М. Сеченова. 2017;103(12):1377-1394.
17. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16 (3):233-270. doi:10.1093/ehjci/jev014
18. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) Method. Methods. 2001;25(4):402-8. doi:10.1006/meth.2001.1262
19. KnyazevaA, Krutikov A, GolovkinA, MishaninA, Pavlov G, Smolina N et al. Time- and ventricular-specific expression profiles of genes encoding Z-Disk proteins in pressure overload model of left ventricular hypertrophy. Front Genet. 2019;9:684. doi:10.3389/fgene.2018.00684
20. Sergeeva IA, Christoffels VM. Regulation of expression of atrial and brain natriuretic peptide, biomarkers for heart development and disease. Biochim Biophys Acta. 2013;1832 (12):2403-13. doi:10.1016/j.bbadis.2013.07.003